1988
DOI: 10.1038/336257a0
|View full text |Cite
|
Sign up to set email alerts
|

Hormone binding globulins undergo serpin conformational change in inflammation

Abstract: A surprising recent finding is that thyroxine binding globulin (TBG) and cortisol binding globulin (CBG), are members of the serine protease inhibitor (serpin) superfamily. Apparently evolution has completely adapted the serpin structure for its new role in these proteins as a transport agent, as there is no evidence of any retained protease inhibitory activity. This drastic change in function raises the question as to why such a complex molecular framework has been selected for the relatively simple task of h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
262
0
4

Year Published

1994
1994
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 391 publications
(278 citation statements)
references
References 10 publications
12
262
0
4
Order By: Relevance
“…This has been seen in all inhibitory serpins tested as well as in the noninhibitory TBG and CBG [44]. Ovalbumin and angiotensinogen notably lack this transition [38].…”
Section: Experimental Clues To Conformational Properties the Occurrenmentioning
confidence: 94%
“…This has been seen in all inhibitory serpins tested as well as in the noninhibitory TBG and CBG [44]. Ovalbumin and angiotensinogen notably lack this transition [38].…”
Section: Experimental Clues To Conformational Properties the Occurrenmentioning
confidence: 94%
“…However, the serpin family includes also members that show no protease inhibitory activity. These serpins function in diverse biological processes, such as hormone transport (thyroxinebinding globulin) (24), blood pressure regulation (angiotensinogen) (25), tumor suppression (maspin) (26), and angiogenesis (pigment epithelium-derived factor) (27). In other cases, functional, inhibitory serpins display additional activities, as exemplified by C1 inhibitor (C1 INH), which shows anti-inflammatory effects including endotoxin binding (28), and protein C inhibitor (PCI), which exerts direct antimicrobial effects (29).…”
Section: Discussionmentioning
confidence: 99%
“…The release of ligands from CBG at their sites of action is controlled in a targeted manner, as illustrated by crystal structure studies [1]. The best example for this is at sites of inflammation neutrophil elastase cleaves CBG at a single site in a surface exposed reactive center loop, which causes a significant rearrangement in the tertiary structure of CBG that disrupts steroid-binding, thus providing a highly efficient mechanism for the local release of cortisol [11][12][13]. As there is evidence that CBG is the target of other proteinases [9], CBG accumulated at the maternal-fetal interface [6] can be cleaved by placenta-specific proteinases and thus involved in regulating local progesterone bioavailability and action.…”
Section: Special Topicmentioning
confidence: 99%